Abstract. Ankyrins are a family of large, membraneassociated proteins that mediate the linkage of the cytoskeleton to a variety of membrane transport and receptor proteins. A repetitive 33-residue motif characteristic of domain
isoforms of ankyrin at 190 and 210 kD in these tissues, nor in bovine brain, nor with ankyrin from human erythrocytes. Ank6u 9 remains extractable in 0.5% Triton X-100, and assumes a punctuate cytoplasmic distribution in mature MDCK cells, in contrast to the Tritonstable plasma membrane localization of all previously described renal ankyrins. AnkG119 immunoreactivity in subconfluent MDCK cells distributes with the Golgi complex in a pattern coincident with [3-COP and [3IE* spectrin immunoreactivity. A fusion peptide containing residues 669-860 of AnkG119 interacts with [3IE1 spectrin in vitro with a Kd = 4.2 _+ 4.0 (__-2 SD) nM, and avidly binds the [3 spectrin in MDCK cell lysates. Collectively, these data identify AnkGu9 as a novel small ankyrin that binds and colocalizes with I3IE* spectrin in the ER and Golgi apparatus, and possibly on a subset of endosomes during the early stages of polarity development. We hypothesize that Ank6119 and 13I spectrin form a vesicular Golgi-associated membrane skeleton, promote the organization of protein microdomains within the Golgi and trans-Golgi networks, and contribute to polarized vesicle transport.
NTERACTIONS between integral membrane proteins and the underlying spectrin-actin cytoskeleton play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains (Luna and Hitt, 1992; Bennett and Gilligan, 1993; Devarajan and Morrow, 1996; Morrow et al., 1996) . Ankyrins are a family of large, membrane-associated proteins that have emerged as crucial adapter molecules mediating such linkages, since they possess recognition sites for various membrane proteins as well as for cytoskeletal elements (Bennett, 1992) . Molecules using a 33-residue re-and is widely present in neuronal and glial cell membranes, as well as in a variety of nonneuronal tissues including the kidney. It is the product of the ANK2 gene . At least two alternatively spliced mRNA transcripts of 9 and 13 kb are generated from this gene Otto et al., 1991) . AnkG is an immunologically distinct isoform found at the plasma membrane at the nodes of Ranvier and at the axon initial segments (Kordeli et al., 1990 (Kordeli et al., , 1995 Kordeli and Bennett, 1991) . It is the product of the ANK3 gene (Peters et al., 1995) . Although two transcripts of the Ank G gene (15 and 10 kb) are neural-specific, smaller, alternatively spliced isoforms may be expressed in the kidney and lung (Kordell et al., 1995; Peters et al., 1995) . In addition, a 72-kD truncated ankyrin that binds spectrin and is localized with the membrane protein GP85 has been detected immunologically in T lymphocytes; its gene of origin is unknown (Bourguignon et al., 1986) .
Such isoform diversity may be critical to maintain a specific pattern of protein distribution in neurons and polarized epithelial cells such as those of the kidney tubules that directionally transport ions and nutrients. It is likely that such tissues harbor additional isoforms of ankyrin. Antibodies raised against AnkR recognize a 210-kD product in erythrocytes and a 190-kD polypeptide in kidney tissue (Davis et al., 1989; Morrow et al., 1991) . The Ank R from both sources binds spectrin and Na,K-ATPase (Devarajan et al., 1994) . AnkR-deficient NB/NB mice, however, express the 190-kD renal ankyrin, indicating that it is encoded by a gene distinct from ANK1, presumably an ANK3 gene (Bennett, 1992) . Antibodies to Ank B crossreact with a 220-kD peptide in kidney tissue, but AnkB eDNA probes hybridize only weakly to renal RNA , suggesting that the kidney Ank B peptide may also be the product of a distinct gene. Finally, antibodies to Ank~ recognize polypeptides in the 190-72-kD range in rat kidney (Kordeli et al., I995) , none of which have been further characterized.
In this study, we describe the cDNA cloning, characterization, and intracellular localization of a small ll9-kD ankyrin isoform (AnkGng) from kidney tissues. After this work was first submitted, a report describing Ank C in the brain appeared (Kordeli et al., 1995) . Comparison with that sequence reveals the ankyrin we have cloned to be an alternative transcript of the larger form that was identified in brain. Therefore, we now refer to this form as Ank~119, rather than AnkK, as had been previously reported in abstract form (Devarajan, P., A. Mann, T. Ardito, P. Stabach, M. Kashgarian, and J.S. Morrow. 1995. Mol. Biol. Cell. 6: 269a) and in the initial version of this report. AnkG119 possesses only part of the repeats domain characteristic of all previously described ankyrins, and also deletes almost the entire regulatory domain. AnkGl~9 is expressed in the kidney, placenta, and skeletal muscle, in MDCK cells (a collecting tubule line), and in cultured porcine proximal tubule cells (LLC-PK1). The distribution of this small ankyrin in rat kidney cells and in confluent MDCK and LLC-PK1 cells is cytoplasmic and Golgi associated, unlike the plasma membrane localization of all other previously described ankyrin isoforms. AnkG119 also specifically binds MDCK cell 13I~* spectrin (erythroid-like) in vitro with nanomolar affinity, and is coincidentally distributed in the Golgi apparatus with a previously described Golgi-associated I3IE* spectrin (Beck et al., 1994) . These findings significantly extend the known diversity of the ankyrins, confirm the presence of a Golgi-associated 13IE* spectrin, and strongly imply that these two proteins function together as an integral part of the Golgi apparatus. We speculate that as with the plasma membrane, specialized variants of spectrin and ankyrin organize microdomains within the ER, Golgi, and trans-Golgi networks, and may play a pivotal role in the process of targeted membrane assembly.
Materials and Methods

Isolation of Renal Ankyrin Clones
All molecular biological procedures were carried out using standard methods (Sambrook et al., 1989) . Oligonucleotides bracketing a 255-bp conserved region within the spectrin-binding domain of human erythrocyte ankyrin were used in standard PCR reactions (Innis and Gelfand, 1990) . The sense primer was 5'-GCCCAGTGGGAAGACATAACAGG-3'; the antisense primer was 5'-CTI~GTCCAC'ITrATCATCTGTCATG -CAG-3'. Five templates were amplified: (a) human kidney eDNA library (Clontech Laboratories, Palo Alto, CA); (b) rat kidney eDNA library (Clontech); (c) rat kidney RNA reverse transcribed with random hexamer priming and avian myeloblastosis virus reverse transcriptase (Boehringer Mannheim Biochemicals, Indianapolis, IN); (d) MDCK cell RNA reverse transcribed as described above; and (e) LLC-PK1 cell RNA reverse transcribed as described above. Water was used as a negative control for all PCR reactions. The absence of genomic DNA in the RNA samples was confirmed by the absence of amplified PCR products when no reverse transcriptase was used. PCR products were subcloned into the TA vector (Invitrogen, San Diego, CA), and both strands were sequenced by the dideoxynucleotide chain termination method (U.S. Biochemical Corp., Cleveland, OH). Subsequently, the random primer 3Zp-labeled PCR product was used to screen the human kidney eDNA library to isolate several overlapping clones. One rescreening of the library was required to obtain the 5' end and complete the AnkG119 cDNA sequence.
Northern Blot Analysis of mRNA Expression
Human multiple-tissue nylon membrane blots containing poly-A-selected mRNAs (Clontech) were hybridized to a random primer 3~P-labeled cDNA probe (the 255-bp PCR product) encoding human kidney ankyrin or a control probe for actin and washed at high stringency. Hybridized bands were detected by autoradiography using X-OMAT film (Eastman Kodak Co., Rochester, NY) and fluorescent intensifying screens.
Preparation of Antibodies to Ank~n9
Antibodies to Ankc119 were produced from a recombinant peptide. The 255-bp PCR product from human kidney eDNA library was ligated in-frame to the expression vector pGEX-1N via the EcoR1 site. The pGEX vectors (Pharmacia Fine Chemicals, Piscataway, NJ) direct the bacterial synthesis of foreign proteins as a fusion peptide with glutathione S-transferase (GST) 1 (Smith and Johnson, 1988) . Overnight cultures of transformed Escherichia coil were induced with 1 mM isopropy113-D-thiogalactoside for 5 h at 37°C, pelleted, and resuspended in sonication buffer (containing 50 mM Tris-HCl, 50 mM NaCI, 1 mM EDTA, 1 mM PMSF, 10 p,g/ml leupeptin, 10 p.g/ml aprotinin, 1 mM DTT, 1 mM benzamidine, pH 8). After overnight storage at -80°C, the suspension was thawed, brought to 1% (vol/ vol) Triton X-100, and sonicated at 70 W for 15 s, repeated three times, with a sonic power apparatus (Branson Ultrasonics Corp., Danbury, CT). The lysate was centrifuged at 48,000 g for 20 rain, and the supernatant was affinity purified on a 2-ml glutathione-agarose column. The pelleted material was extracted by solubilization in 6 M urea, 50 mM glycine, pH 9.0, and successively dialyzed in 2, 1, 0.5, and 50 mM urea (each with 50 mM glycine, pH 9.0), and then affinity purified as described before. Extraction of the pellet yielded a 25-fold increase in the amount of fusion peptide obtained. The two fractions were pooled, rebound to a glutathione-agarose column, eluted with 50 mM Tris-HCl/5 mM reduced glutathione, pH 8.0, and dialyzed into PBS. Aliquots were analyzed by SDS-PAGE, and 0.1 ml (at 40 mg/ml) was injected subcutaneously into New Zealand white rabbits in complete Freund's adjuvant for antibody production . Antibody titers of hyperimmune sera were monitored by ELISA assay using recombinant AnkoHg.
Preparation of Cell and Tissue Lysates
The outer renal cortices of Sprague-Dawley rats were harvested in 5 ml of PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, 2 mM MgCl2, pH 6.9) containing 0.2% Triton X-100, 0.5 mM PMSF, 10 }xg/ml leupeptin, and 0.1 mM DTI" (Van Why et al., 1992) . After homogenization with a Potter-Elvehjem homogenizer and centrifugation at 35,000 g for 14 min at 4°C, the pellets were resuspended in a volume of PHEM extraction buffer equal to that of the supernatants, and aliquots of each fraction were analyzed by SDS-PAGE and Western blotting (Molitoris et al., 1992) .
MDCK cells grown to confluence in 150-cm 2 culture flasks in DME medium supplemented with 10% FBS and antibiotics were sequentially extracted in situ as described before Devarajan ct al., 1994) . Five extractions were performed: buffer 1 (yielding Fxl) contained 10 mM Pipes, pH 6.8, 100 mM NaC1, 300 mM sucrose, 3 mM MgC12, 0.5% Triton X-100, 1.2 mM PMSF, 0.5 mM Pefabloc SC; buffer 2 (yielding Fx2) substituted 250 mM ammonium sulfate for NaC1, but was otherwise identical to buffer 1; buffer 3 (yielding Fx3) was similar to buffer 1 but contained 50 mM NaCI, 100 ~g/ml of DNAse I, 100 lxg/ml RNAse, and 33 mg/ ml ammonium sulfate; buffer 4 (yielding Fx4) was 10 mM Tris-HCl, pH 7.4, 9.5 M urea; buffer 5 (yielding Fx5) was 10 mM Tris-HCl, pH 7.4, 1% (vol/vol) 2-mercaptoethanol, 9.5 M urea. Protein in the MDCK cell extracts was assayed by Peterson's modification of the Lowry method (Peterson, 1983) . Interfering buffer components were removed by precipitation of the protein with trichloroacetic acid in the presence of sodium desoxycholate (Bensadoun and Weinstein, 1976) . Analysis of these fractions by Western blots has shown that ~65% of the immunodetectable spectrin is in Fx2, but a significant quantity (~30%) is also found in Fxl (data not shown), as has been previously reported for the 210-kD isoform of ankyrin in MDCK cells (Devarajan et al., 1994) .
Protease Digestions
Human erythrocyte ghosts and MDCK cell lysate soluble (fxl) and cytoskeletal (fx2) fractions were subjected to limited tryptic digestion . Each sample at ~1 mg/ml total protein was exhaustively dialyzed against trypsin digestion buffer (5 mM NaHPO4, 20 mM KCI, 1 mM EDTA, 0.5 mM 2-mercaptoethanol, pH 7.6) and then treated with trypsin (L-l-tosylamido-2-phenylethyl chtoromethyl ketonetreated; Worthington Biochemical Corp., Freehold, N J) at an enzyme/ substrate ratio of 1:20 at 0°C for 30 min. Reactions were terminated by boiling with 4x solubilizing buffer containing 12% (wt/vol) SDS, 5 M urea, 250 mM Tris-HCl, pH 7.5. Aliquots were analyzed by SDS-PAGE and Western blotting with AnkR-and Ankol19-reactive antiserum. Alternatively, the same substrates were subjected to digestion with }x-calpain (Harris et al., 1989) after dialysis into calpain digestion buffer (20 mM Tris, 25 mM NaCl, 5 mM DTT, pH 7.5). Purified }L-calpain from porcine erythrocytes (Nacalai Tesque, Inc., Kyoto, Japan) was diluted immediately before use 1:10 into 50 mM Tris, 1 mM DTT, pH 7.5, and added to each sample at a 1:100 (vol/vol) ratio. Before the addition of ix-calpain, each sample was brought to 100 }xM in CaC12. Digestion was allowed to proceed for 20 rain at 30°C, and was terminated by boiling as described above.
Expression of Recombinant Ankcu 9 Constructs
Three sets of oligonucleotides were designed as shown in Fig. 8 a, so as to create three constructs spanning residues 457~592 (Ank W, 1595-2205 bp), 669-860 (Ank J, 2135-2709 bp), and 850-1058 (Ank Y, 2680-3303 bp), all within the putative spectrin-binding domain of AnkGll9. Using the clone HKA R as template (Fig. 1) , these constructs were amplified by standard PCR, subcloned, and sequenced to verify their identity. They were then ligated in-frame into the pGEX vectors, expressed in bacteria as fusion peptides with GST, and purified on a glutathione-agarose column (Devarajan et al., 1994) . GST alone was also expressed as a control peptide. The four recombinant pepfides were eluted, dialyzed into spectrin-binding buffer (FBB; 50 mM Tris-HCl, pH 8.0, 50 mM NaC1, 1 mM DTT, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 1 mM benzamidine, 1 mM Pefabloc SC), and aliquots were analyzed by SDS-PAGE and quantified by protein assay (Bio Rad Laboratories, Hercules, CA). Each fusion (50 }xg at 1 mg/ ml) was conjugated to 50 I~1 of a 50% slurry of glutathione-agarose beads for 1 h at 4°C with gentle rotation and used in binding assays.
Binding Assays
The interaction of AnkGll9 with spectrin in the soluble fraction (Fxl) of MDCK cell lysates was assayed in vitro by the ability of conjugated recombinant AnkcH9 peptides to retain spectrin (Devarajan et al., 1994) . Freshly prepared Fxl was dialyzed into FBB and preadsorbed to glutathione-agarose beads conjugated with GST alone for 4 h at 4°C. After pelleting at 13,000 g for 1 min, the supernate (~500 I~g total protein) was allowed to interact with each of the four fusion peptides (50 }xg each, previously conjugated to GST and beads) at 4°C overnight with gentle rotation. The beads were pelleted and washed twice with FBB, and the aliquots were analyzed by SDS-PAGE. Bound spectrin was detected by Western blotting, with antibody directed against the 13IE* spectrin subunit.
The interaction of Ankcn9 with 131 spectrin was measured quantitatively using spectrin purified from fresh human erythrocytes (Morrow and Marchesi, 1981) and biotinylated by reaction of a 3 mg/ml solution in PBS with a 12-fold molar excess of sulfo-N-hydroxysuccinimide-biotin (Pierce Chemical Co., Rockford, IL) at 0°C for 2 h. Excess biotin was removed by exhaustive dialysis against PBS. Recombinant AnkGn9 peptide or control GST was incubated overnight in PBS with increasing amounts of labeled spectrin. Bound and free fractions were separated by absorption to glutathione-agarose as described before (Kennedy et al., 1994) and analyzed by SDS-PAGE. Free and bound spectrin were measured by an overlay assay using HRP-avidin and enhanced chemiluminescence (Kennedy et al., 1994) . Each determination was compared to a series of standard protein loads using the same biotinylated spectrin and developed on the same transfer membrane. Binding results were analyzed by nonlinear regression after subtraction of the nonspecific binding to GST controls. All data was fitted as simple bimolecular binding, minimizing the degrees of freedom of the fit.
Immunofluorescence and Confocal Microscopy
Cells were fixed and labeled in a modification of a previously used protocol for intact tissues (Van Why et al., 1992) . Briefly, cells grown to confluence in Lab-Tek eight-chamber slides were fixed by exchanging the tissue culture media with one rapid wash of PBS followed by paraformaldehyde-lysineperiodate fixative (PLP) for a minimum of 1 h at room temperature (McLean and Nakane, 1974) . Cells were then washed three times in PBS and used immediately for labeling, or they were stored in holding buffer (PBS 0.2% formaldehyde) at 4°C for a maximum period of 10 d until labeling. On the day of labeling, the cells were gently permeabilized by freeze-thawing. In this procedure, the cells were treated with PBS, 10% DMSO for 15 min, and then rapidly frozen on an aluminum block at -35°C. They were then thawed by immersion in PBS, 1% BSA, 1% normal goat serum, and were allowed to remain in this solution to block nonspecific staining for 1 h at room temperature. Labeling of ankyrin antibodies was accomplished by exposing the cells to a titrated solution of preimmune and immune sera diluted in PBS, 1% BSA, 0.1% normal goat serum for I h at room temperature. Slides were gently agitated at 15-min intervals. The cells were then washed three times in PBS, and biotinylated anti-rabbit secondary antibody (Vector Laboratories, Burlingame, CA) was applied at a 1:100 dilution in PBS/BSA solution, as done with the primary antibodies. This was followed by an identical third step of exposing the cells to FITC-conjugated avidin (Vector Laboratories) diluted 1:100 in PBS/BSA. Cells in adjacent chambers were labeled with a mAb for Na,K-ATPase using a twostep indirect labeling process involving exposure to the primary antibody, which was then followed after washing with rhodamine-conjugated goat anti-mouse antibody (Cappel/Organon-Teknika, Durham, NC) 1:200 in PBS/BSA. The slides were coverslipped in Vectashield (Vector Laboratories) to retard fading and were edge sealed with Cytosea160 (Stephens Scientific, Inc., Riverdale, N J) mounting media. Confocal microscopy was performed using a Bio Rad MRC-600 scanning laser microscope attached to a standard microscope (Carl Zeiss, Inc., Thornwood, NY) with a Leitz 50× water immersion lens (Leica, Inc., Deerfield, IL). Labeled cells and negative controls were first visualized en face under identical microscope settings that were standardized with respect to illumination intensity, detector amplifier settings, and confocal aperture size. Z section microscopy was also performed on areas of interest to determine apical and basolateral domain staining. In this procedure, the confocal aperture was set at its minimum section thickness, ~1.0 }xm with the objective lens used, and images were collected at 1.2-1~m steps so that no overlap between sections would be observed. Alternatively, conventional indirect fluorescent microscopy was performed using a microscope (AX70; Olympus Corp., Lake Success, NY) equipped for epillumination.
Other Methods
The isolation of total RNA from rat kidney, MDCK cells, and LLC-PK1 ceils used standard methods (Chomczynski and Sacchi, 1987) . SDS-PAGE and Western blotting methods were as described (Laemmli, 1970; Towbin et al., 1979) . Immunodetection of transferred proteins was by enhanced chemiluminescence (Amersham Corp., Arlington Heights, IL). Antibodies to a-Na,K-ATPase, AnkR, and nonerythroid speetrin have been previously characterized Devarajan et al., 1994) . The antibody to 13-COP was a kind gift from Dr. Ira Mellman (Yale University, New Haven, CT) and has been previously described (Pepperkok et al., 1993; Whitney et al., 1995) . The mAb to 13I spectrin was mAb VIIIC7, which reacts with epitopes near the center of 13I spectrin (Harris et al., 1986) .
Results
Cloning and Characterization of a Novel Ankyrin from Kidney Tissues (AnkG119 )
A comparison of published eDNA sequences encoding human erythrocyte (Lambert et al., 1990; Lux et al., 1990a ) and brain ankyrins revealed a region of sequence conservation in the spectrin-binding domain (between residues 1183 and 1268 of human erythrocyte ankyrin). Oligonucleotides bracketing this highly conserved region amplified a 255-bp product by PCR from five kidney ternplates: a human kidney eDNA library, a rat kidney eDNA library, reverse-transcribed MDCK cell RNA, reverse-transcribed LLC-PK1 cell RNA, and reverse-transcribed rat kidney RNA (Fig. 1 a) . Nucleotide sequencing of several positive clones from each of the PCR reactions revealed that regardless of the templates that were used, just two families of sequences were detected (Fig. 1 b) . One family included proteins that were highly homologous or identical to human brain ankyrin, reinforcing immunologic data that AnkB is expressed in renal tissues . The other family of ankyrins (AnkG) included sequences that were closely related to each other (>90% identity over the 255-bp region amplified by PCR) but were dissimilar to any recognized ank~rins from brain or erythrocytes. Comparing the human sequences over this region, AnkG119 displayed ~58 and ~64% identity at the nucleotide level (55-69% identity at the amino acid level) to AnkR and AnkB, respectively (Fig. 1 c) . Subsequent comparisons to AnkG, which were not available when these studies were carried out, reveal 100% identity at the amino acid and DNA levels over this region, confirming that it arises from the same gene as AnkG (ANK3).
Using the 255-bp PCR product as a probe, three overlapping clones encoding a unique ankyrin sequence (HKA B, HKA S, and HKA R) were identified in the human kidney eDNA library (Fig. 1 d) . Rescreening the library with HKA R yielded two additional overlapping clones (HKA Z (c) Comparison of the derived human amino acid sequences of AnkR, AnkB, and Ank6119 over the amplified spectrin-binding domain. Conserved amino acids are indicated by dashes. Human Anka and AnkGn9 share 66% and 56% amino acid identity, respectively, to human Ank R over this region. (d) Overlapping AnkGl~9 clones obtained by screening a human kidney cDNA library first with the AnkGll9 PCR product (HKA B, S, R) and then with H K A R (HKA Z, X). Comparison of the full-length deduced amino acid sequence with Ank R and AnkB allowed the delineation of a 47-kD domain consisting of 13 ankyrin repeats, a 67-kD spectrin-binding domain, and a very truncated 5-kD regulatory domain.
and HKA X), confirming a contiguous 3454-bp cDNA sequence for AnkGH9 (GenBank No. U43965) with a putative polyadenylation signal (AATAAA) 17 bp upstream of the poly(A) ÷ tail (Fig. 2) . The cDNA sequence has a single open reading frame (with stop codons in all three reading frames upstream of the initiator methionine), and it encodes for a protein of 1,089 amino acids with a predicted molecular weight of 119,201 and isoelectric point of 8.2.
Comparison of the deduced Ankou9 amino acid sequence with previously described ankyrins allows for the delineation of three putative ankyrin domains (Fig. 2) . After a unique 5'-flanking sequence, AnkGH9 encodes just 13 33-residue repetitive motifs characteristic of the ankyrins, in contrast to the 22-24 copies of this motif found in all previously described ankyrins. As a result, domain I of AnkGu 9 is 47 kD. The Ankol m repeats are identical to repeats 12-24 of Anko and homologous to repeats 11-22 in AnkR and AnkB, indicating that Ankon9 is devoid of the first 10-11 repeats found in other ankyrins. The Ankou 9 repeats domain is followed by a 67-kD putative spectrinbinding domain with strong homology to other ankyrins and a remarkably shortened 5-kD regulatory domain (starting with A-L-R as in AnkR) (Lux et al., 1990a), but is then followed by unique sequence. This divergent regulatory domain cannot be an artifact of concatamer formation during library construction because it has been identified in two distinct clones (Fig. 1) , and reverse transcription PCR amplification of RNA derived from kidney tissue using primers flanking the junction between the homologous ankyrin-like sequence and the novel 3' domain generated the predicted product (data not shown). Interestingly, these primers did not amplify any products from brain RNA, suggesting that this 3' end is unique to Ankolt9. Overall, Anko119 is highly homologous to Ank~, and partially homologous to AnkB and AnkR, suggesting that AnkoH 9 is a tissue-specific, alternatively spliced, and truncated isoform of Anko, but possesses unique 5' and 3' ends.
While the similarities noted above clearly indicate that it
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arises from the same gene, AnkGll9 differs from brain AnkG in several respects. Pairwise sequence alignment of AnkGt19 vs brain AnkG using either Bestfit (University of Wisconsin Genetics Computer Group) (Devereux et al., 1984) or MegAlign (DNASTAR, Inc., Madison, WI) reveals five specific regions of deleted or altered sequence. The first six residues of Ankc119 are unique, as are the first 385 residues of brain AnkG. 
AnkG119 Is Expressed Primarily in Kidney, Placenta, and Skeletal Muscle
Northern blot analysis of AnkG119 mRNA expression using the 255-bp PCR product as a probe revealed a major 6.0-kb transcript in the human kidney, placenta, and skeletal muscle, and in rat kidney tissue. Upon longer exposures, the AnkGt19 cDNA probe also hybridized with a 7-kb message in kidney tissue, 9-and 14-kb species in the brain, 8-and 9-kb messages in the heart, and faint 7--8-kb messages in intestinal tissues and ovary (Fig. 3) . No message was detected in leukocytes or in the liver. Presumably, these bands represent either cross-hybridization with other ankyrins (given the strong sequence conservation between different ankyrins over some part of their structure), or more likely, other alternatively spliced products of the AnkG gene (Kordeli et al., 1995; Peters et al., 1995) . Hybridization of these blots after stripping of the AnkG~19 cDNA probe with a human "v-actin cDNA probe revealed equal loading of the actin message in all lanes.
Antibodies to AnkGu9 Recognize a ll6-kD Peptide in the Soluble Pools of Renal Cell Lysates
A recombinant peptide representing the 255-bp PCR product of AnkG119 (Fig. 1 , clone H K A P) was prepared and (Fx2, lane 2) , as previously noted (Devarajan et al., 1994) . purified as a fusion protein with GST. This peptide was used to generate a polyclonal antibody that specifically recognized this fusion protein on Western blots (Fig. 4 a) . This antibody did not react with any proteins in erythrocyte ghosts or in the bovine brain. A protein with an apparent molecular mass of 116 kD was detected in MDCK cells and in C2C12 cells, a myoblast cell line. By comparison, an antibody to AnkR detected immunoreactive bands between 190 and 220 kD in all cell samples, representing previously described ankyrin species. These observations were refined by examining the solubility properties of the peptide being detected by anti-AnkGx19. Unlike the 190-kD ankyrin recognized by AnkR antibodies, the ll6-kD AnkG119 was present only in the Triton-soluble fraction of rat kidney cortical tissue (Fig. 4 b) .
A similar segregation of the ll6-kD peptide into a soluble pool was also apparent in cultured confluent MDCK cells. Under conditions of sequential extraction of various cellular elements, we have previously demonstrated that the 210-kD immunological counterpart of AnkR in MDCK cells is found predominantly in the "cytoskeletal" fraction (Fx2) (Devarajan et al., 1994) . Under identical extraction conditions, the ll6-kD AnkG119 is found exclusively in the soluble pool (Fig. 4 c) .
Ankat19 Codistributes with Golgi Markers and fllZ* Spectrin
Immunofluorescence confocal microscopy with antibodies to AnkGll9 produced a largely diffuse but punctuate cytoplasmic staining in stable and highly confluent MDCK cells (Fig. 5, c and f) , as well as in LLC-PK1 cells and intact renal tubule cells (data not shown). In contrast, antibodies directed against ANKR demonstrated a basolateral and somewhat apical membrane distribution (Fig. 5, b and e) , while the distribution of the et subunit of Na,K-ATPase (Fig. 5, a and d) was basolateral, as expected in these mature MDCK cells. The etII[3II spectrin (fodrin) in these cells was also predominantly localized to the basolateral membrane (data not shown) (Nelson and Veshnock, 1986; Koob et al., 1988; Morrow et al., 1989) .
When isolated or subconfluent MDCK cells were examined, a different intracellular distribution became apparent (Figs. 6 and 7) . Under these conditions, in which full epithelial cell polarity had not yet been established, intense anti-AnkG119 staining was concentrated eccentrically near the nucleus, with less punctuate cytoplasmic staining apparent (Figs. 6, a and d, and 7 a) . This pattern was strongly suggestive of Golgi staining and was confirmed as such by its coincidence with the staining pattern of [3-COP (Fig. 6, e and g ). [3-COP is the best-characterized component of the cytoplasmic coatamer proteins that assemble on COP I vesicles involved in the transport of newly synthesized proteins between the ER, the Golgi, and the trans-Golgi network (Pepperkok et al., 1993; Griffiths et al., 1995) . Recent data has also implicated [3-COP in the function of some types of endosomes (Whitney et al., 1995) . AnkGH9 was also found to be colocalized in the Golgi with 13I~* spectrin, as revealed by its coincident immunostaining with mAb VIIIC7 (Figs. 6, b and h, and 7 b) .
The 116-kD AnkGu 9 Is Not a Proteolytic Fragment of a Conventional Ankyrin
The size of the AnkGl19-immunoreactive peptide, as well as its cytoplasmic and Golgi distribution, are novel for a member of the ankyrin superfamily. Previous work has demonstrated that proteolysis of ankyrin from either brain or red cells yields fragments in the size range of 40-120 kD, and that many of these fragments lack the putative membrane-binding domain (Davis and Bennett, 1984; . Therefore, the reactivity of the anti-AnkG119 antibody with proteolytic fragments of conventional renal ankyrins was of concern. To exclude the possibility that the anti-AnkG119 was recognizing only a new epitope created by the proteolysis of a conventional ankyrin, extracts Figure 5 . The distribution of Ank6119 is cytoplasmic and distinct from that of AnkR by indirect immunofluorescent microscopy. Cultured MDCK cells were fixed and immunostained after several days at confluence to determine the distribution of (a and d) a-Na,K-ATPase, (b and e) AnkR, and (c and f) Ank6119. Note the punctate cytoplasmic distribution of Ank6119 compared to the plasma membrane compartmentalization of both Anka and Na,K-ATPase. In such confluent and stably polarized cells, the association of AnkGn9 with Golgi membranes is largely inapparent (compare with Fig. 6 ). The z-axis micrographs in d-f were constructed from a series of z-axis line scans recorded at 1.2-1xm levels using the standard BioRad 600 confocal microscope software. Bar, 10 ixm.
of MDCK cells were subjected to proteolysis with either p~-calpain or trypsin, and the resulting breakdown products were examined by Western blotting with either the AnkGll9 or AnkR antibodies. Erythrocyte ghosts were also Devarajan et al. Golgi-associatedAnk3,rin examined in these assays. Both the conventional 210-kD renal ankyrin (recognized by anti-AnkR in the cytoskeletal fraction, Fx2) and the ll6-kD AnkG119 (in the soluble fraction, Fxl) were degraded by these proteases (Fig. 8) . The AnkG119 antibody reacted with a breakdown product at ~20 kD in the soluble fraction after trypsin treatment. No breakdown products were detected after ~-calpain treatment. The AnkR antibody recognized an array of breakdown products after p~-calpain and trypsin treatment in erythrocyte membranes and in the cytoskeletal fraction of MDCK cells, although the fragmentation patterns were not identical (Fig. 8) . Importantly, no 116-kD peptide that would react with the AnkG119 antibody was generated at any point in the proteolysis of the cytoskeletal fraction of MDCK cells or of red cell ghosts. The pattern of fragments generated from the proteolysis of AnkG~9 was also not a subset of the fragments generated by similar conditions of proteolysis of the AnkR, based on their molecular weights. These distinct patterns of proteolytic breakdown and immunoreactivity between renal AnkG119 and AnkR indicate that the 116-kD Ankol19-immunoreactive protein observed in the cytoplasmic pool cannot be merely a proteolytic fragment of a conventional, membrane-associated renal ankyrin. Since AnkG119 was identified based on homologies in ankyrin's spectrin-binding domain, it was of interest to determine if the 116-kD AnkGv9 retained bonafide spectrinbinding activity. The putative spectrin-binding domain of Anko119 was expressed in bacteria as three overlapping GST fusion peptides (Fig. 9 a) , purified over a bioaffinity column, and assayed for its ability to retain spectrin from fxl (soluble) of MDCK cell lysates. Each of the recombinant peptides was soluble, stable, and of the predicted molecular weight by SDS-PAGE analysis (Fig. 9 b) . Only peptide pGEX-HKA J specifically and reproducibly bound both 13II-spectrin (Fig. 9 b) and ~I-spectrin (Fig. 9 c) . This peptide represents residues 669-860 of AnkGt19 (Fig. 9, shaded area), a region highly conserved between all known ankyrin isoforms (100% homology with AnkG, 80% with AnkB, and 67% with AnkR). Interestingly, the spectrinbinding domain previously identified in residues 1136-1160 of AnkR (Platt et al., 1993) is highly homologous to AnkGn9 residues 801-825 contained within the spectrinbinding recombinant peptide pGEX-HKA J.
AnkG119 Binds to M D C K
Given the coincident localization of AnkGH9 with 13IE* spectrin in MDCK cells (Fig. 8) , the strength of the interaction between these proteins was of interest. The I3IE* spectrin in kidney cells remains incompletely characterized although it is immunologically most similar to the [3I~1 spectrin from erythrocytes (Beck et al., 1994) , a point further confirmed by its reactivity with mAb VIIIC7 reported here. Therefore, the ability of the AnkGn9 spectrinbinding domain to associate with 13IE1 spectrin from red cells was measured (Fig. 10) . These two proteins interacted strongly, with an apparent Kd = 4.2 _ 4.0 (+_2 SD) nM. AnkG119 with biotinylated cdl~I spectrin was measured quantitatively by incubating increasing amounts of biotinylated erythrocyte spectrin with a fixed amount of the pGEX2T-AnkJ construct or GST alone, after which the AnkJ peptide with any bound spectrin was separated by absorption to glutathione-Sepharose, analyzed by SDS-PAGE, and the amount of bound spectrin was determined (in arbitrary units) by overlay with HRP-avidin. The extent of binding is expressed as a fraction of the maximal binding (Fig. 2) is depicted. The relationship of these constructs to the full-length Ank~119 amino acid sequence is depicted in the bar at the top of the figure with the residue numbers indicated. The shaded area represents the minimal spectrin-binding domain that is identified in these studies. (b) Top, Coomassie blue-stained SDS-PAGE gel showing, respectively, from left to right GST alone at 27.5 kD, the Ank W, Ank J, and Ank Y fusion peptides, and the soluble fraction (fxl) from MDCK cell lysates. Bottom, Western blot of the lysate retained by each fusion peptide and of Fxl alone, using an antibody directed against 131I spectrin. Note that only the AnkJ construct interacted with 13II spectrin in MDCK cell fx 1. (c) Western blot of the same lysate as in b that was retained by each fusion peptide and of Fxl alone, now using mAb VIIIC7 antibody directed against 13IE* spectrin. Again, note that the AnkJ peptide also interacts with this form of 13 spectrin from the MDCK cell fxl. abundant in the kidney, placenta, and skeletal muscle; (e) AnkG119 binds spectrin with high affinity; Q') AnkG119 does not associate with the plasma membrane; (g) AnkG119 and 13IE* spectrin are colocalized with 13-COP in incompletely polarized (subconfluent) M D C K cells; and (h) AnkG119 is a substrate in vitro for trypsin but resists ~-calpain digestion. Collectively, these studies substantively expand our understanding of the ankyrin gene superfamily, and they suggest that members of this family of proteins, together with other components of the spectrin-actin skeleton, may play a role in intracellular vesicle trafficking or other processes that transcend plasma membrane "anchoring" functions.
The possible relationship of AnkG119 to the only other known "small ankyrin," the 72-kD ankyrin-like molecule previously described in T lymphocytes (Bourguignon et al., 1986) , is provocative. In that study, a molecule with immunologic and peptide map similarities to ankyrin was found to bind both spectrin and the membrane protein GP85. It is unlikely that this molecule was AnkG119, since AnkGa19 is larger in size, is not found in lymphocytes, and is not associated with the plasma membrane. However, other alternative transcripts of AnkG appear to exist (Kordeli et al., 1995; Peters et al., 1995) , and in several other respects, the lymphocyte 72-kD ankyrin appears similar to AnkGv9. While sequence or cloning data on the lymphocyte ankyrin is lacking, certain conclusions can be surmised. Both molecules are smaller than conventional ankyrins. Both bind spectrin, and thus must presumably conserve the central spectrin-binding domain of ankyrin. Both lack part or all of the repetitive 33-residue domain that is characteristic of the conventional ankyrins. This region is responsible for membrane binding, and its partial absence in AnkGa19 may explain the solubility of AnkG119. We postulate that the defining characteristic of these unconventional ankyrins will be their spectrin-binding capacity, and that linked to the spectrin-binding motif by exon splicing or other mechanisms will be additional protein cassettes bestowing alternative functionality on different members of this putative family. Indeed, the putative basic minimal spectrin-binding motif R R R K F H ( K / R ) first identified in AnkR (Platt et al., 1993) is strongly conserved in all known ankyrin sequences irrespective of their tissue distribution, including AnkB , AnkG (Kordeli et al., 1995) , Drosophila ankyrin (Dubreuil and Yu, 1994) , and Ank~119 (residues 802-808, Fig. 2 ). Also supportive of this notion is the marked diversity in alternative 5' and 3' transcripts being recognized that originate from the ANK1 (erythroid) and ANK3 genes despite complete conservation of the spectrin-binding domain (GaP lagher et al., 1992; Birkenmeier et al., 1993; Kordeli et al., 1995; Peters et al., 1995) .
The structural basis for the failure of AnkGn9 to associate with the plasma membrane may be inferred from its deduced amino acid sequence. It has been shown that the plasma membrane-binding domain of conventional ankyrins consists of 22-24 tandemly arrayed repeats that fold into four independently folded subdomains of six repeats each (Michaely and Bennett, 1993) . All four sets of six repeats are required for proper folding into a membrane-binding globular configuration, with removal of even a single repeat resulting in a 40% loss of a helicity. All four of the six-repeat subdomains have also been implicated in the binding of ankyrin to the anion exchanger (AE1) (Davis et al., 1991; Michaely and Bennett, 1993) . The loss of the first 11 repeat units in Ank~119 is therefore anticipated to render Ankclt9 unable to bind AE1. It remains undetermined whether Ank~tt9 retains binding capacity for other integral proteins, such as Na,K-ATPase, which may interact at different sites within ankyrin Davis and Bennett, 1990; Devarajan et al., 1994) . However, AnkGt19 almost certainly retains some membrane-binding properties, since it appears to be closely associated with various intracellular membrane compartments involved with membrane protein biogenesis and polarized assembly.
The association of AnkGt19 (and 13I~* spectrin) with the Golgi is unexpected and provocative, and suggests that these proteins play a role in the function of this structure. Work over the past two decades has established a comprehensive picture of many aspects of intracellular vesicle trafficking (reviewed in Kreis and Pepperkok, 1994; Matter and MeUman, 1994; Robinson, 1994) . At least three classes of transport vesicles are derived from the ER, the Golgi, and the plasma membrane, respectively. Each of these is characterized not only by specific integral membrane proteins displaying either apical or basolateral targeting signals, but also by the assembly of peripheral protein coats that tend to be distinct for each vesicle type. These coats are believed to control the budding of nascent transport vesicles and the sorting of specific components to each vesicle. The best understood of these coats is the clathrin complex characteristic of plasma membrane-derived endosomes, as well as one class of vesicles budding from the trans-Golgi network (Robinson, 1994) . The other two classes of vesicles, COP I and COP II, mediate transport between the ER and through the Golgi to the trans-Golgi network. COP I vesicles form by the recruitment of a coatamer that consists of at least seven distinct subunits, of which ~-COP is one component. These coatamer components have also been recently identified on certain endosomes derived from the plasma membrane, suggesting that their function may be more general than first envisioned (Whitney et al., 1995) . The assembly of COP I vesicles is disrupted by brefeldin A treatment. The results reported here, together with earlier findings that brefeldin A disrupts the association of [~IE* spectrin with the Golgi of MDCK cells (Beck et al., 1994) , suggest that AnkGlx9 and [3IE* spectrin must now be added to the list of coatameric proteins that are characteristic of this class of vesicles.
The functional significance of a 13IE* spectrin and AnkGlt9 association with components of the ER and Golgi remains uncertain. At the plasma membrane, the spectrin-actin and ankyrin complex acts to control the lateral organization of integral membrane proteins and to organize membrane microdomains (reviewed in Bennett and Gilligan, 1993; Morrow, et al., 1996) . This is probably its most fundamental role, rather than direct membrane support . By analogy, one would expect that the Golgi-13IE* spectrin and AnkG119 complex acts to organize microdomains within these membrane compartments and perhaps link them to the filamentous actin cytoskeleton or to other filamentous components via spectrin's well-established binding capacities. Such a linkage, if required for polarized vesicular transport, would establish a molecular basis for the heretofore unexplained sensitivity of polarized vesicular transport to agents that disrupt actin filaments (Kelly, 1991) . A problem with this hypothesis is the relative paucity of Ank6n9 in other epithelia, such as enterocytes or hepatocytes (see Fig. 3 ). Perhaps other isoforms of ankyrin exist in these lines. Alternatively, and perhaps more likely, the abundance of Ank6119 in different cell types may vary greatly, perhaps reflecting the balance between a cell's use of the trans-Golgi network for sorting vs transcytotic pathways, with only those that sort predominantly in the trans-Golgi network using AnkGlt9.
Consonant with this hypothesis would be the predominance of this ankyrin in MDCK and kidney cells (in which trans-Golgi network sorting pathways predominate, Matter and Mellman, 1994) and the diminution of AnkGlt9 in Golgi under confluent [steady-state] conditions in which transcytotic pathways may assume greater importance (Mays et al., 1995) . It will be of interest to explore these novel and testable hypotheses in future studies.
